One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papers
Open Accesshttps://doi.org/10.1182/blood.2023022937
Copy DOI Journal: Blood |  Publication Date: Dec 17, 2023 |
 Citations: 4 |  License type: CC BY-NC-ND 4.0 |
Affiliation: Essen University Hospital, Hôpital Lyon Sud, Université Paris Cité, Centre Hospitalier Universitaire de Limoges, Groupe Hospitalier de l'Institut Catholique de Lille, Hôpital Saint-Louis, University Hospital Heidelberg, Centre Hospitalier Universitaire de Poitiers, University Medical Center Utrecht, National and Kapodistrian University of Athens, University of LimogesTeclistamab shows promising results in R/R AL amyloidosis, with VGPR or better in 88% of patients and involved FLC < 10 mg/L in 76%. We observed a 35% rate of severe infections and no cardiac or kidney related events.
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
